You are viewing: Spain Nucleic Acid Isolation and Purification Market analysis

The Spain Nucleic Acid Isolation and Purification Market was valued at $48.62 Million in 2026 and projected to reach to $71.52 Million by 2031, representing a compound annual growth rate of 8.0%. Spain's nucleic acid isolation and purification market is positioned for sustained growth through 2031, supported by increasing investments in genomic research infrastructure and diagnostic capabilities.

Spain Nucleic Acid Isolation and Purification Market Trends and Insights

  • This 8.0% compound annual growth rate reflects Spain's increasing investment in genomic research, diagnostics, and biotechnology infrastructure.
  • Spain's healthcare sector is driving demand for advanced nucleic acid extraction technologies across clinical laboratories, research institutions, and pharmaceutical companies. The Spanish market benefits from strong government support for life sciences innovation and a growing prevalence of genetic testing and personalized medicine initiatives.
  • Spain's position within the European Union enables access to collaborative research networks and regulatory frameworks that facilitate market expansion.
  • By 2031, Spain is expected to solidify its role as a key hub for nucleic acid isolation technologies in Southern Europe, supported by rising adoption in COVID-19 testing, cancer genomics, and infectious disease diagnostics. Key drivers include Spain's expanding pharmaceutical R&D sector, increased funding for precision medicine programs, and growing clinical demand for rapid, high-quality nucleic acid extraction solutions.
  • Spain's market growth trajectory aligns with broader European trends toward automation and high-throughput processing capabilities..

Key Market Statistics

  • CAGR (2026-2031) : 8.0% CAGR
  • Market Size, 2026 : ~USD 48.62
  • Forecast, 2031 : ~USD 71.52
  • Country : Spain

Spain Nucleic Acid Isolation and Purification Market Overview

Market Valuation Growth :

Spain's nucleic acid isolation and purification market is valued at $48.62 million in 2026, with projections reaching $71.52 million by 2031, representing an 8.0% CAGR driven by expanding genomic research initiatives.

Healthcare Infrastructure Investment :

Spain's robust healthcare sector is increasingly investing in advanced nucleic acid extraction technologies, supporting diagnostic capabilities and personalized medicine development across major research institutions and hospitals.

Genomic Research Expansion :

Growing demand for genomic sequencing and molecular diagnostics in Spain is accelerating adoption of isolation and purification solutions among research centers, clinical laboratories, and biotechnology companies.

Biotechnology Sector Growth :

Spain's emerging biotechnology ecosystem is fostering innovation in nucleic acid processing, with increased funding and collaboration between academic institutions and private sector players strengthening market development.

Spain Nucleic Acid Isolation and Purification Market Dynamics

  • The country's healthcare modernization initiatives and emphasis on precision medicine are driving demand for advanced extraction technologies across clinical and research settings.
  • Spanish laboratories and biotech firms are increasingly adopting automated and high-throughput purification systems to enhance efficiency and accuracy in molecular diagnostics and research applications.
  • Government support for life sciences innovation and growing collaboration between academic institutions and private enterprises will further accelerate market expansion, establishing Spain as a key player in Southern Europe's molecular biology sector..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Danaher Corporation

    Biotechnology

    Top Technologies
    • Reagents
    • Polymerase Chain Reaction (PCR)
    • Stem Cells
    • Assay Kits
    • Flow Cytometers
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.

      Key Takeaways

      • Spain's nucleic acid isolation market is valued at $48.62 million in 2026 and will reach $71.52 million by 2031, representing an 8.0% CAGR.
      • Spain's healthcare and pharmaceutical sectors are primary growth drivers, fueled by increased genomic research and personalized medicine adoption.
      • Spain benefits from EU regulatory frameworks and collaborative research networks that accelerate technology adoption and market expansion.
      • Rising demand for diagnostic testing, including COVID-19 and cancer genomics applications, is propelling Spain's market growth through 2031.

      Spain Nucleic Acid Isolation and Purification Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment CELL-FREE SAMPLES (Sample Type)
      Forecast Period 2026–2031
      Growth Rate CAGR of 8.7% from 2026 to 2031
      Largest Segment CELLULAR SAMPLES (Sample Type)
      Market Size Base Year 6.37 (2026)
      Revenue Forecast 9.66 (2031)
      Segments Covered Product, Type, Method, Sample Type

      Spain Nucleic Acid Isolation and Purification Market Report Segmentation

      4 segment dimensions are covered across the global market.

      By Product

      • Instruments
      • Kits
      • Reagents

      By Type

      • Automatic Instruments
      • Bacterial Cells
      • Cfdna/Ctdna
      • Circulating Nucleic Acid Isolation And Purification
      • Cultured Cells
      • Ffpe
      • Fresh/Frozen Tissues
      • Genomic Dna Isolation And Purification
      • Manual Instruments
      • Messenger Rna Isolation And Purification
      • Microrna Isolation And Purification
      • Other Cell-Free Samples
      • Other Cellular Samples
      • Other Nucleic Acid Isolation And Purification Types
      • Other Preserved Tissue Samples
      • Plasmid Dna Isolation And Purification
      • Total Rna Isolation And Purification
      • Wbcs

      By Method

      • Column-Based Isolation And Purification
      • Magnetic Bead-Based Isolation And Purification
      • Other Isolation And Purification Methods
      • Reagent-Based Isolation And Purification

      By Sample Type

      • Cell-Free Samples
      • Cellular Samples
      • Other Samples
      • Preserved Tissue Samples

      Target Audience

      • Spanish Diagnostic Laboratory Operators : Need market insights to evaluate equipment investments, understand competitive positioning, and plan capacity expansion aligned with Spain's growing molecular diagnostics demand.
      • Biotechnology and Pharmaceutical Companies : Require Spain-specific market data to assess market entry feasibility, identify customer segments, and develop localized product strategies for the Spanish biotech ecosystem.
      • Healthcare System Administrators : Need market intelligence to justify budget allocations for genomic research infrastructure, evaluate technology vendors, and align procurement with Spain's healthcare modernization goals.
      • Research Institution Directors : Seek market data to support funding proposals, benchmark laboratory capabilities against Spanish peers, and identify emerging technologies for genomic research advancement.
      • Medical Device and Reagent Suppliers : Require Spain-focused market analysis to identify growth opportunities, understand customer needs, and develop targeted sales strategies for nucleic acid isolation products.

      Key Companies in the Spain Nucleic Acid Isolation and Purification Market

      CompanyHQOwnershipStrongest segments
      SIGMA-ALDRICH CORPORATIONUnited StatesPrivate CompanyAnalytical chemistry, labware, and materials science,Cell culture media, critical raw materials, and industrial microbiology,Molecular biology, functional genomics, and protein biology,
      BECKMAN COULTERUnited StatesPrivate CompanyClinical diagnostics (chemistry, immunoassay, hematology, urinalysis, hemostasis),Flow cytometry and cellular analysis,Life science research tools (centrifugation, genomics, liquid handling, spectrophotometry),
      FLUOR CORPORATIONUnited StatesPublic CompanyEnergy Solutions (traditional and transition EPC),Urban Solutions (AT&M, life sciences, mining, infrastructure),Mission Solutions (government, nuclear remediation, security),
      SANOFIFrancePublic CompanyVaccines (pediatric, RSV, hexavalent, travel),Immunology & Inflammation,Rare Diseases & Neurology,
      GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (including Ultrasound and Image-Guided Therapies),Patient Care Solutions,
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
      QIAGEN N.V.NetherlandsPublic CompanySample technology consumables and instruments,Immune response and infectious disease diagnostics,Oncology and sexual/reproductive health assays,
      MERCK KGAAGermanyPublic CompanyLife Science,Healthcare,Electronics,
      DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic solutions),Diagnostics (clinical instruments, consumables, software),
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
      BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science Research & Bioprocess,
      ILLUMINA, INC.United StatesPublic CompanySequencing instruments,Sequencing consumables (reagents, flow cells, library prep),Array-based products,
      TAKARA BIO INC.JapanPrivate CompanyGenetic and cellular research reagents,PCR instruments and cellular analysis devices,In vitro diagnostics (including COVID-19),
      REVVITY INC.United StatesPublic CompanyDiagnostics (prenatal, neonatal, infectious disease, immunodiagnostics),Life science reagents and assay platforms,Instruments, imaging, and detection systems,
      BIONEER CORPORATIONSouth KoreaPublic CompanyPCR / RT-PCR and real-time PCR reagents and instruments,Molecular diagnostics kits and MDx extraction systems,Research reagents, RNAi, chemicals, buffers, and consumables,

      SIGMA-ALDRICH CORPORATION

      Sigma-Aldrich Corporation is a United States-based private company founded in 1951 that employs 9,800 people. The company specializes in providing research chemicals, biochemicals, and laboratory supplies to the scientific community.

      BECKMAN COULTER

      Beckman Coulter is a United States-based private company founded in 1935 with 11,900 employees. The company manufactures and distributes laboratory instruments and diagnostic equipment.

      FLUOR CORPORATION

      Fluor Corporation is a United States-based public company founded in 1912 with 22,995 employees. The company provides engineering, procurement, and construction services across multiple industries.

      SANOFI

      Sanofi is a France-based public company founded in 1994 with 74,846 employees. The company is a global pharmaceutical organization engaged in the research, development, and commercialization of medicines.

      GE HEALTHCARE

      GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees. The company provides medical imaging, diagnostics, and healthcare IT solutions.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. The company is a global leader in serving science, providing laboratory equipment, reagents, and analytical instruments.

      QIAGEN N.V.

      QIAGEN N.V. is a Netherlands-based public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics and life sciences research products.

      MERCK KGAA

      Merck KGaA is a Germany-based public company founded in 1668 with 59,077 employees. The company operates in pharmaceuticals, life sciences, and performance materials sectors.

      DANAHER CORPORATION

      Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees. The company operates a diversified portfolio of businesses in life sciences, diagnostics, and environmental solutions.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees. The company provides laboratory instruments, software, and services for life sciences and diagnostics.

      BIO-RAD LABORATORIES, INC.

      Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research products and clinical diagnostics equipment.

      ILLUMINA, INC.

      Illumina, Inc. is a United States-based public company founded in 1998 with 8,625 employees. The company develops and manufactures DNA sequencing and genetic analysis systems.

      TAKARA BIO INC.

      Takara Bio Inc. is a Japan-based private company founded in 2002 with 1,779 employees. The company specializes in biotechnology products and services for research and diagnostics.

      REVVITY INC.

      Revvity Inc. is a United States-based public company founded in 1937 with 11,000 employees. The company provides analytical instruments, software, and services for life sciences and diagnostics.

      BIONEER CORPORATION

      Bioneer Corporation is a South Korea-based public company founded in 1992 with 392 employees. The company develops and manufactures molecular biology reagents and diagnostic products.

      Reasons to Buy this Report

      • Spain-Specific Market Sizing : Access precise valuation data for Spain's market ($48.62M in 2026), enabling accurate budgeting and investment decisions tailored to the Spanish nucleic acid isolation sector.
      • Competitive Landscape Intelligence : Understand Spain's unique competitive dynamics, key players, and market positioning within the broader European context to identify partnership and expansion opportunities.
      • Growth Driver Analysis : Identify Spain-specific factors driving the 8% CAGR, including healthcare investments, genomic research initiatives, and biotechnology sector development for strategic planning.
      • Regulatory and Infrastructure Insights : Gain detailed understanding of Spain's healthcare regulations, laboratory standards, and research infrastructure requirements affecting product adoption and market entry strategies.
      • Forecast-Based Strategic Planning : Leverage 2031 projections ($71.52M) to develop long-term market strategies, resource allocation plans, and product development roadmaps specific to Spain's growth trajectory.

      Frequently asked questions

      What is the current market size of nucleic acid isolation and purification in Spain?

      Spain's nucleic acid isolation and purification market is valued at $48.62 million in 2026, with expectations to grow to $71.52 million by 2031.

      What is the projected growth rate for Spain's nucleic acid isolation market?

      Spain's market is projected to grow at a compound annual growth rate (CAGR) of 8.0% from 2026 to 2031.

      What are the main drivers of growth in Spain's nucleic acid isolation market?

      Key drivers include increased genomic research investment, rising adoption of personalized medicine, growing diagnostic testing demand, and Spain's expanding pharmaceutical R&D sector.

      Which sectors in Spain are driving demand for nucleic acid isolation technologies?

      Spain's clinical laboratories, research institutions, pharmaceutical companies, and diagnostic centers are primary demand drivers for nucleic acid isolation and purification solutions.

      How does Spain's EU membership impact its nucleic acid isolation market?

      Spain's EU membership provides access to harmonized regulatory frameworks, collaborative research networks, and cross-border partnerships that facilitate market growth and technology adoption.

      RESEARCH METHODOLOGY

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global nucleic acid isolation and purification market. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of leading market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.

      Secondary Research

      Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the global nucleic acid isolation and purification market. The secondary sources used for this study include WHO Disease Statistics (Oncology, Genetic Disorders), CMS Clinical Laboratory Improvement Amendments (CLIA) Laboratory Lists, Association of Public Health Laboratories (APHL) List, Regional Forensic Laboratories list, State Office of Chief Medical Examiner (OCME) List, Biocluster List of Members (Massbio, NC Bio, CLSA), Organization for Economic Co-operation and Development (OECD) R&D Expenditure, National Animal Health Laboratory Network (NAHLN) laboratories List, Genome Canada Membership List, Genome Canada Laboratories Network, Canada Statistics Business Enterprise R&D Statistics, EudraGMP Sites, Biodeutschland Member List, European Federation of Pharmaceutical Industries and Associations (EFPIA) R&D Spending, European Union Drugs Agency (EUDA) Network of forensic and toxicological laboratories list, EudraGMP Sites, BioIndustry Association Member List, NHS Genomics Laboratories Hub, UK Health Security Agency's Laboratories List, FranceBiotech List, China Pharmaceutical Industry Association (CPIA) Member List, China Chinese Center for Disease Control and Prevention (CDC) National Institute for Viral Disease Control and Prevention (IVDC) Laboratories, Japan Pharmaceutical Manufacturers Association (JPMA) & Japanese Bankers Association (JBA) Statistics, NIID (National Institute of Infectious Diseases) reference labs, Indian Pharmaceutical Association (IPA) and Organisation of Pharmaceutical Producers of India (OPPI) Membership List, Brazilian Association of Research-Based Pharmaceutical Industries (Interfarma), Fiocruz Genomic Network Institutes, KAUST Research and Technology Park Companies, Saudi Public Health Authority (Weqaya) National Reference Laboratory System, African Biomedical Engineering Consortium List, Africa CDC Pathogen Genomics Initiative (Africa PGI) Sequencing Laboratories; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, professional associations. These sources were also used to obtain key information on major players, market classification, and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.

      Primary Research

      Following an initial assessment of the global nucleic acid isolation and purification market landscape through secondary research, comprehensive primary research was undertaken. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from pharmaceutical and biotechnology firms, CROs, CMOs, and academic and research institutions. Additionally, interviews were conducted with key supply-side participants, including C-suite and senior executives, product managers, and marketing and sales leaders from prominent manufacturers, distributors, and channel partners. The research covered six major geographical regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while 30% were conducted with demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and telephonic discussions to comprehensively understand market dynamics.

      Nucleic Acid Isolation and Purification market 
 Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both bottom-up and top-down approaches were used to estimate and validate the total size of the global nucleic acid isolation and purification market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • A list of the major global players operating in the nucleic acid isolation and purification market was generated.
      • The revenues generated from their nucleic acid isolation and purification product portfolios have been determined through annual reports and secondary sources (including paid databases).
      • The products were mapped according to the segments of the market. Percentage shares and splits were determined based on each segment's revenue contribution. This was verified using secondary sources and by industry experts.
      • All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.

      Nucleic Acid Isolation and Purification market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, as applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Nucleic acid isolation and purification is a set of molecular biology techniques used for the extraction of DNA and RNA for use in downstream applications, such as sequencing, cloning, and polymerase chain reaction. These downstream applications are important parts of life science research, molecular diagnostics, forensics, and genetic engineering. The report defines the Nucleic acid isolation and purification market as the supplier revenue market for kits, reagents, and instruments used for method, application, type of nucleic acid, and type of samples as described below in the inclusions and exclusions.

      Key Stakeholders

      • OEMs, contract manufacturers, and distributors of nucleic acid isolation and purification kits, reagents, and instruments
      • Start-ups, platform technology & service providers
      • Diagnostic centers, government hospitals, and private clinics
      • Pharmaceutical & biotechnology companies
      • Contract research organizations and other service providers
      • Government institutions & associations funding pharmaceutical & biotechnology R&D
      • Venture capitalists and investors
      • Research associations related to genomics
      • Forensic laboratories
      • Veterinary hospitals/clinics
      • Food testing laboratories

      Report Objectives

      • To define, describe, and forecast the global nucleic acid isolation and purification market based on product, method, type, sample type, application, and end user
      • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the nucleic acid isolation and purification market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments concerning six main regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
      • To profile the key players in the global nucleic acid isolation and purification market and comprehensively analyze their product portfolios, market positions, and core competencies
      • To analyze competitive developments such as product approvals and launches, expansions, agreements, and collaborations in the nucleic acid isolation and purification market
      • To benchmark players within the nucleic acid isolation and purification market using the company evaluation matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations to meet your company's needs. The following customization options are available for this report:

      Portfolio Assessment

      • Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.

      Company Information

      • Detailed analysis and profiling of additional market players (up to three).

      Geographical Analysis

      • A further breakdown of the Rest of Asia Pacific nucleic acid isolation and purification market into countries
      • A further breakdown of the Rest of Europe nucleic acid isolation and purification market into countries
      • A further breakdown of the Rest of Latin America nucleic acid isolation and purification market into countries

       

      Get the Full Nucleic Acid Isolation and Purification Market Report

      Full forecast, segment splits, and company analysis for all Nucleic Acid Isolation and Purification Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status